{"TopicDetails": {"type": 0, "ccm2Id": 46696057, "cftId": 0, "identifier": "HORIZON-JU-GH-EDCTP3-2024-02-01-two-stage", "title": "Global Health EDCTP3 JU training fellowship with return phase", "publicationDateLong": 1705449600000, "callIdentifier": "HORIZON-JU-GH-EDCTP3-2024-02-two-stage", "callTitle": "Coordination and Support actions supporting the Global Health EDCTP3 Joint Undertaking", "callccm2Id": 46696111, "allowPartnerSearch": true, "frameworkProgramme": {"id": 43108390, "abbreviation": "HORIZON", "description": "Horizon Europe Framework Programme (HORIZON)"}, "programmeDivision": [{"id": 43108557, "abbreviation": "HORIZON.2.1", "description": "Health"}, {"id": 43108541, "abbreviation": "HORIZON.2", "description": "Global Challenges and European Industrial Competitiveness"}], "topicMGAs": [], "tags": ["health", "clinical trials", "edctp", "clinical development", "edctp3", "sub-Saharan Africa", "global health", "pharmaceutical company", "manufacturing", "Training", "infectious diseases", "neglected infectious diseases", "fellowships", "clinical research capacity", "skills development", "Africa", "training", "clinical research"], "keywords": ["Global health", "Clinical research", "Emerging Epidemics", "Neglected Infectious Diseases", "Africa", "Tuberculosis", "Respiratory systems", "Social sciences and humanities", "Clinical trials", "Diarrhoeal diseases", "Infectious diseases", "Vaccines", "Public health", "Malaria", "HIV/AIDS", "Societal Engagement", "International Cooperation"], "flags": ["Africa", "SSH", "SocietalEngagement", "EC-WORLD"], "sme": false, "actions": [{"status": {"id": 31094503, "abbreviation": "Closed", "description": "Closed"}, "types": [{"typeOfAction": "HORIZON-JU-CSA HORIZON JU Coordination and Support Actions", "typeOfMGA": [{"id": 43027846, "abbreviation": "HORIZON-AG", "description": "HORIZON Action Grant Budget-Based"}]}], "plannedOpeningDate": "18 January 2024", "submissionProcedure": {"id": 31094505, "abbreviation": "two-stage", "description": "two-stage"}, "deadlineDates": ["04 April 2024", "01 October 2024"]}], "latestInfos": [], "budgetOverviewJSONItem": {"budgetTopicActionMap": {"3545055": [{"action": "HORIZON-JU-GH-EDCTP3-2024-02-01-two-stage - HORIZON-JU-CSA HORIZON JU Coordination and Support Actions", "plannedOpeningDate": "18 January 2024", "deadlineModel": "two-stage", "deadlineDates": ["04 April 2024", "01 October 2024"], "budgetYearMap": {"2024": 3500000}, "expectedGrants": 1, "minContribution": 3500000, "maxContribution": 3500000, "budgetTopicActionMap": {}}]}, "budgetYearsColumns": ["2024"]}, "description": "<SPAN class=\"topicdescriptionkind\">ExpectedOutcome</SPAN>:<p>Project results are expected to contribute to the following outcomes:</p><ul level=\"0\"><li>Foster the culture of pharmaceutical innovation and entrepreneurship in sub-Saharan Africa;</li><li>Increase the number of skilled clinical researchers and innovators in sub-Saharan Africa;</li><li>Promote the career development and retention of skilled personnel in sub-Saharan Africa;</li><li>Strengthen sub-Saharan African countries clinical human capital base in Research and Innovation (R&amp;I);</li><li>Enhance talent retention, knowledge circulation and uptake across the research and innovation landscape in sub-Saharan Africa;</li><li>Establish sustainable and mutually beneficial collaboration between clinical research organisations, academia, and Industry Partners across sub-Saharan Africa and Europe.</li> </ul>\n<SPAN class=\"topicdescriptionkind\">Scope</SPAN>:<p><strong><u>Background:</u></strong></p><p>Sub-Saharan Africa (SSA) has a disproportionally low number of skilled researchers and innovators working on interventions against infectious diseases that are highly prevalent in SSA. To establish a sustainable and robust ecosystem of clinical research and innovators in sub-Saharan Africa synergy between funders, academia, and industry is planned to advance relevant skills. This Global Health EDCTP3 training fellowship programme will target early and mid-career African global health scientists seeking international academic credentials and other professional enrichment.</p><p>By providing this funding for return-home R&amp;D studies, after a period training enriched with industry mentorship, the fellowship programme will enable the alumnae fellows to position themselves as pivotal leaders in improving global health and R&amp;D equity.</p><p>Where relevant, it will be important for proposals to consider and support the existing and emerging partnerships between the EU/Team Europe and the AU and their key agencies, notably the Team Europe Initiatives on MAV+, One Health, Public Health Institutes, and the collaboration with the Africa CDC and the AMA. Moreover, collaborations with the African Regional Intellectual Property Organization (ARIPO) and the African Intellectual Property Organisation (AIPO) should also be fostered as well as strengthened promoting the development and assessment of innovative tools.</p><p>It will also be important that the projects arising from this call will contribute to the implementation of the short-term and medium-term actions of the AU-EU Innovation Agenda around Public Health.</p><p><strong><u>Scope: </u></strong></p><p>Proposals submitted to this topic should implement a master\u2019s level training programme in a discipline relevant for the Global Health EDCTP3 JU, providing transferable R&amp;D skills, fostering innovation and entrepreneurship, incl. commercialisation of results, Intellectual Property Rights, communication, public engagement, and citizen science. The training provided by the academic institutions is expected to be complemented by training modules provided by pharmaceutical companies. It is expected that pharmaceutical companies will join the consortium as beneficiaries and/or associated partners at a later stage. The companies are expected to bring cash or in-kind contributions to the training programme for the fellows</p><p>The training will address the research and development value chain from pre-clinical to clinical research including pharmaceuticals and vaccines.</p><p>Proposals must demonstrate all of the following:</p><ul level=\"0\"><li>A high-quality training programme related to R&amp;D on diseases in the scope of the Global Health EDCTP3 JU at master level in global health/clinical research;</li><li>An open, fair and transparent procedure for selecting the fellows coming from different geographical regions of SSA, based on quality and with appropriate gender balance;</li><li>Design of a programme where training for each fellow includes a <strong>first phase (or outgoing phase)</strong> of minimum 12 and maximum 24 months enrolment into an academic organization, and a <strong>second phase (or return phase)</strong> of at least 12 months in the country of origin of the fellow;</li><li>A robust training and mentorship mechanisms to support the fellows through their first training phase and second home return phase;</li><li>Linkages with other Global Health EDCTP3 JU actions should be foreseen as relevant (e.g. Global Health EDCTP3 Training Networks or Global Health EDCTP3 Genomic Epidemiology Networks).</li> </ul><p>Proposals should be made by institutions with a proven track record in the provision of high-quality research training and established regional and global collaborations. These may include research organisations, institutions of higher learning such as universities.</p><p>The proposals must explain how many fellows they plan to recruit, what the cost of the training in the first phase will be and how much funding will be provided to the fellows for the return phase.</p><p>Based on the described skills and curricula offered by the successful consortium, future fellows will apply to the available training opportunities in line with their own professional development plans.</p><p>Proposals should also clearly outline how future fellows will be mentored in the development and implementation of the second phase (return phase) at the home institution in SSA.</p><p>In-kind and financial contributions from private (profit and non-profit) entities, clinical research organisations and others interested in this scheme are encouraged. Financial contributions can be made with or without direct participation in the project implementation.</p><p>Especially, consortium members established in countries that are not eligible for the Global Health EDCTP3 JU funding, will have to cover the costs related to their tasks within the project without JU funding.</p><p>Financial contributions from third parties (e.g., foundations) interested in this scheme are encouraged to contribute to increase the budget, diversity, and impact.</p>\n<SPAN class=\"topicdescriptionkind\">Expected Impact</SPAN>:<p><strong><u>Expected Impacts</u></strong></p><p>Activities funded under the 2024 work programme of the Global Health EDCTP3 JU calls for proposals should contribute to:</p><ul level=\"0\"><li>Achieve SDG3 \u2018Ensure healthy lives and promote well-being for all at all ages\u2019 in sub-Saharan African (SSA) countries; </li><li>Enable the implementation of the short- and medium-term actions foreseen by the AU EU Innovation Agenda (adopted in July 2023) in the area of public health and the EU Global Health Strategy (November 2022); </li><li>Improve equitable access to a full range of essential health services from health promotion to disease prevention and affordable quality treatment, rehabilitation and palliative care to fight communicable diseases;</li><li>Expand partnerships based on equal footing, co-ownership, mutual interest and strategic priorities;</li><li>Enhance sustainable global scientific collaboration in health research and international cooperation across sub-Saharan Africa.</li><li>Improve opportunities for training of researchers and healthcare professionals in sub-Saharan Africa.</li> </ul>\n", "conditions": "<h1><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: medium;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\" style=\"line-height: 115%;\">General conditions</span></b></span></span></span></h1>\r\n<p class=\"MsoNormal\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">1. Admissibility conditions: </span></b><span lang=\"EN-US\">described in </span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex A</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> </span><span style=\"color: rgb(0, 0, 0);\"><span lang=\"EN-US\">and </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:&#10;Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex E</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of the Horizon Europe Work Programme General Annexes</span></span></span></p>\n<p style=\"margin-left: 40px;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Proposal page limits and layout:</span></b><span lang=\"EN-US\"> described in Part B of the Application Form available in the Submission System</span></span></span></span></p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">2. Eligible countries: </span></b><span lang=\"EN-US\">described in </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;&#10;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex B</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> </span></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">of the Work Programme General Annexes</span></span></span></span><span lang=\"EN-US\" style=\"mso-ansi-language:EN-US\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-left: 40px;\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects. See the information in the </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:&#10;minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Horizon Europe Programme Guide</span></span></a></span></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">.</span></span></span></p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b style=\"mso-bidi-font-weight:normal\"><span lang=\"EN-US\">3. Other eligibility conditions:</span></b><span lang=\"EN-US\"> described in </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:&#10;Calibri;mso-bidi-theme-font:minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex B</span></span></a></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"> <span lang=\"EN-US\">of the Work Programme General Annexes</span></span></span></span></p>\n<p><strong><u>Replacing relevant sections in General Annex B to the Horizon Europe work programmes on eligibility </u></strong><strong>(\u201c<em>Entities eligible for funding\u201d) </em></strong></p><p>To become a beneficiary, legal entities must be eligible for funding.</p><p>To be eligible for funding, applicants must be established in one of the following countries:</p><ul level=\"0\"><li>The Member States of the European Union, including their outermost regions: Austria, Belgium, Bulgaria, Croatia, Cyprus, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden;</li><li>The Overseas Countries and Territories (OCTs) linked to the Member States: Aruba (NL), Bonaire (NL), Cura\u00e7\u00e3o (NL), French Polynesia (FR), French Southern and Antarctic Territories (FR), Greenland (DK), New Caledonia (FR), Saba (NL), Saint Barth\u00e9lemy (FR), Sint Eustatius (NL), Sint Maarten (NL), St. Pierre and Miquelon (FR), Wallis and Futuna Islands (FR);</li><li>Countries associated to Horizon Europe <sup>[1]</sup>: Albania, Armenia, Bosnia and Herzegovina, Faroe Islands, Georgia, Iceland, Israel, Kosovo <sup>[2]</sup>, Moldova, Montenegro, New Zealand (associated to Pillar II 'Global Challenges and European Industrial Competitiveness' as from the Work Programmes 2023 onwards, including for the institutionalised European partnerships), North Macedonia, Norway, Serbia, Tunisia, Turkey, Ukraine, United Kingdom.</li> </ul><p>Until association agreements start producing legal effects either through provisional application or their entry into force, transitional arrangements apply. The transitional arrangements apply, at the time of the adoption of this Work Programme, with regard to the following countries and legal entities established in these countries, with which association negotiations are being processed or where association is imminent):</p><p>1. Canada</p><p>2. Morocco</p><ul level=\"0\"><li>The following countries which are constituent states of the EDCTP Association <sup>[3]</sup>: Benin, Burkina Faso, Cameroon, C\u00f4te d\u2019Ivoire, Democratic Republic of the Congo, Ethiopia, Gabon, The Gambia, Ghana, Guinea-Bissau, Guinea-Conakry, Kenya, Liberia, Malawi, Mali, Mozambique, Niger, Nigeria, Republic of the Congo, Rwanda, Senegal, Sierra Leone, Somalia, South Africa, Tanzania, Uganda, Zambia, Zimbabwe.</li> </ul><p><strong><em><u>Consortium composition </u></em></strong></p><p>Unless otherwise provided for in the specific call conditions, for all actions, due to the policy objectives of the Global Health EDCTP3 JU, legal entities forming a consortium are eligible to participate in actions under the programme provided that the consortium includes:</p><ul level=\"0\"><li>At least three legal entities independent from each other and established in different countries, where legal entities are eligible to receive funding;</li><li>At least one independent legal entity established in a Member State or an associated country; and</li><li>At least one independent legal entity established in a sub-Saharan African (SSA) country that is a member of the EDCTP Association.</li> </ul><p>This condition applies to both Research and Innovation Actions (RIA) and Coordination and Support Actions (CSA).</p><p><strong><em>Specific cases:</em></strong></p><p><strong>Affiliated entities </strong>\u2014 Affiliated entities (i.e. entities with a legal or capital link to a beneficiary<sup>[4]</sup> which participate in the action with similar rights and obligations to the beneficiaries, but which do not sign the grant agreement and therefore do not become beneficiaries themselves) are allowed, if they are eligible for participation and funding.</p><p><strong>Associated partners </strong>\u2014 Entities not eligible for funding (and therefore not able to participate as beneficiaries) may participate as associated partners, unless specified otherwise in the specific call conditions.</p><p><strong>International organisations</strong> \u2013 International European research organisations are eligible to receive funding. Other international organisations are not eligible to receive funding unless their participation is considered essential for implementing the action by the granting authority. International organisations with headquarters in a Member State or associated country are eligible to receive funding when provided for in the specific call conditions.</p><p><strong><em><u>Specific rules regarding legal entities that may be the coordinator of an indirect action</u></em></strong></p><p>In accordance with Article 110(2) of the Council Regulation 2021/2085 establishing the Joint Undertakings under Horizon Europe<sup>[5]</sup>, where entities established in a third country without an agreement to protect the financial interests of the Union participate with funding in an indirect action, the financial coordinator of the indirect action must be established in a Member State or associated country. Of the SSA countries members of the EDCTP Association, only South Africa concluded such an agreement at the moment.<sup>[6]</sup></p><p><strong><em><u>Scientific project leader</u></em></strong></p><p>If the coordinator is not established in a country in sub-Saharan Africa (SSA), the designation of a scientific project leader established in a SSA country member of the EDCTP Association with the roles as described below is mandatory. A work package on \u2018scientific project leadership\u2019 must be included in the proposals and budget needs to be provided for this activity.</p><p>The scientific project leader oversees the project scientific governance and leadership. For this purpose, proposals must include a work package where the details of scientific project leadership are laid down. The scientific project leader should indicatively perform the following tasks:</p><ul level=\"0\"><li>During the call for proposals and selection process, coordinate meetings on and drafting of the full project proposal;</li><li>Work with the coordinator and other beneficiaries on the drafting and negotiation of the consortium agreement and other legal agreements among the beneficiaries;</li><li>Act as the key contact point for the Global Health EDCTP3 JU regarding all scientific action governance issues, steer and provide oversight in the development of the scientific actions, without prejudice to the tasks entrusted directly to the coordinator as per the Model Grant Agreement;</li><li>Support and collaborate with the coordinator on its monitoring activities and the adoption of appropriate internal measures, to ensure that beneficiaries are fulfilling their obligations regarding budget, timeline, deliverables, and scientific quality;</li><li>Review the action\u2019s deliverables and reports before their submission by the coordinator;</li><li>Lead the work packages(s) related to the tasks of scientific project leadership.</li> </ul><p>Annex 1 to the grant agreement and the consortium agreement should address the relationship of the scientific project leader with the coordinator regarding their respective tasks, for example sharing of the information received from or sent to the Global Health EDCTP3 JU on all issues of interest for the proper scientific management of the action.</p><p><sup>[1]</sup> The list is correct at the time of adoption of this work programme. Please see the Horizon Europe List of Participating Countries on the Funding &amp; Tenders Portal for up-to-date information on the current list and on the position for Associated Countries.</p><p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/list-3rd-country-participation_horizon-euratom_en.pdf\">https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/list-3rd-country-participation_horizon-euratom_en.pdf</a></p><p><sup>[2]</sup> This designation is without prejudice to positions on status and is in line with UNSCR 1244/1999 and the ICJ Opinion on the Kosovo declaration of independence.</p><p><sup>[3] </sup>The list is correct at the time of adoption of this work programme. For an update, please check the EDCTP Association website <a href=\"http://www.edctp.org\">www.edctp.org</a></p><p><sup>[4] </sup>See Article 187 EU Financial Regulation 2018/1046.</p><p><sup>[5]</sup> Council Regulation (EU) 2021/2085 of 19 November 2021 establishing the Joint Undertakings under Horizon Europe and repealing Regulations (EC) No 219/2007, (EU) No 557/2014, (EU) No 558/2014, (EU) No 559/2014, (EU) No 560/2014, (EU) No 561/2014 and (EU) No 642/2014. <em>OJ L 427, 30.11.2021, p. 17\u2013119;</em></p><p><a href=\"https://eur-lex.europa.eu/eli/reg/2021/2085\">https://eur-lex.europa.eu/eli/reg/2021/2085</a></p><p><sup>[6]</sup> <a href=\"https://research-and-innovation.ec.europa.eu/strategy/strategy-2020-2024/europe-world/international-cooperation/south-africa_en\">https://research-and-innovation.ec.europa.eu/strategy/strategy-2020-2024/europe-world/international-cooperation/south-africa_en</a></p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b>4. Financial and operational capacity and exclusion: </b>described in </span></span></span><span style=\"mso-bidi-font-weight:bold\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex C</span></span></a></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"> of the Work Programme General Annexes</span></span></span></p>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"FR-BE\">5.&nbsp;Evaluation and award:</span></b></span></span></span></p>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">\r\n    <p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Award criteria, scoring and      thresholds</span></b><span lang=\"EN-US\"> are      described in </span></span></span></span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex      D</span></span></a></span><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> </span><span style=\"color: rgb(0, 0, 0);\"><span lang=\"EN-US\">of      the Work Programme General Annexes</span></span></span></span><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n    </li>\r\n</ul>\n<p><strong><u>Replacing the <em>scores and weighting</em> section in General Annex D to the Horizon Europe work programmes as regards Research and Innovation Actions (RIA) second stage of two-stage evaluations.</u></strong></p><p><strong><em><u>Scores and weighting</u></em></strong></p><p>Evaluation scores will be awarded for the criteria, and not for the different aspects listed in the table. For full applications, each criterion will be scored out of 5. The threshold for individual criteria 1 (Excellence) and 2 (Impact) will be 4 and for criteria 3 (Quality and efficiency of the implementation) will be 3. The overall threshold, applying to the sum of the three individual scores, will be 12.</p><p>Proposals that pass the individual threshold and the overall threshold will be considered for funding, within the limits of the available call budget. Other proposals will be rejected.</p><p><em>Nota bene</em>, for the first stage of the two-stage evaluation, the scores and weighting as indicated in Annex D of the General Annexes of the Horizon Europe work programme 2023/2024 apply. Furthermore, the scores and weighting for Coordination and Support Actions apply.</p>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">\r\n    <p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Submission and evaluation      processes</span></b><span lang=\"EN-US\"> are      described in </span></span></span></span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex      F</span></span></a></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of      the Work Programme General Annexes and the </span></span></span></span><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Online      Manual</span></span></a><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n    </li>\r\n</ul>\n<ul style=\"margin-top:0cm\" type=\"square\">\r\n    <li class=\"MsoNormal\">\r\n    <p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Indicative timeline for      evaluation and grant agreement: </span></b><span lang=\"EN-US\">described in </span></span></span></span><span class=\"MsoHyperlink\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex      F</span></span></a></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of the Work Programme General Annexes</span></span></span></span><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n    </li>\r\n</ul>\n<p><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b style=\"mso-bidi-font-weight:normal\"><span lang=\"EN-US\">6. Legal and financial set-up of the grants: </span></b><span lang=\"EN-US\">described in </span></span></span></span><span class=\"MsoHyperlink\"><span style=\"mso-bidi-font-family:Calibri;mso-bidi-theme-font:&#10;minor-latin\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Annex G</span></span></a></span></span><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\"> of the Work Programme General Annexes</span></span></span></span></p>\r\n<p>&nbsp;</p>\n<p>Beneficiaries may provide financial support to third parties. The maximum amount to be granted to each third party is EUR 300,000. The support to third parties can only be provided in the form of grants. These grants are the fellowships to be awarded. For multi-annual fellowships, the amount of up to EUR 300,000 is needed.</p>\n<h1><span style=\"font-size: medium;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\" style=\"line-height: 115%;\">Specific conditions</span></b></span></span><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:&#10;11.0pt;line-height:115%;mso-ansi-language:EN-US\"><o:p></o:p></span></b></h1>\r\n<p class=\"MsoNormal\"><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">7. Specific conditions: </span></b><span lang=\"EN-US\">described in the [specific topic of the Work Programme]</span></span></span></span></p>\r\n<p class=\"MsoNormal\">&nbsp;</p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-US\"><o:p></o:p></span></p>\n<h1><span style=\"font-size: medium;\"><b><span lang=\"EN-US\" style=\"line-height: 115%;\"><span style=\"font-family: Arial;\">Documents</span></span></b></span><b><span lang=\"EN-US\" style=\"font-size:12.0pt;mso-bidi-font-size:&#10;11.0pt;line-height:115%;mso-ansi-language:EN-US\"><o:p></o:p></span></b></h1>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span style=\"color: rgb(0, 0, 0);\"><b><span lang=\"EN-US\">Call documents:</span></b></span></span></span><b><span lang=\"EN-US\"><o:p></o:p></span></b></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span style=\"color: rgb(0, 0, 0);\"><span lang=\"EN-US\">Standard application form</span></span><span style=\"color: rgb(128, 128, 128);\"><span lang=\"EN-US\"> &mdash;<i style=\"mso-bidi-font-style:normal\"> call-specific application form is available in the Submission System</i></span></span></span></span><span lang=\"EN-US\"><o:p></o:p></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/af_he-csa_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Standard application form (HE CSA)</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/af_he-csa-stage-1_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Standard application form (HE CSA Stage 1)</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"font-size: small;\"><span style=\"color: rgb(0, 0, 0);\"><span lang=\"EN-US\">Standard evaluation form</span></span><span style=\"color: rgb(128, 128, 128);\"><span lang=\"EN-US\"> &mdash;<i style=\"mso-bidi-font-style:normal\"> will be used with the necessary adaptations</i></span></span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/ef/ef_he-csa_en.pdf\"><span style=\"font-size: small;\"><span lang=\"EN-US\">Standard evaluation form (HE CSA)</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/ef/ef_he-ria-ia-csa-stage-1_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Standard evaluation form (HE RIA, IA and CSA Stage 1)</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"font-size: small;\"><span style=\"color: rgb(0, 0, 0);\"><span lang=\"EN-US\">MGA</span></span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/agr-contr/general-mga_horizon-euratom_en.pdf\" style=\"font-size: small;\"><span style=\"font-size: small;\">HE <span lang=\"EN-US\">General MGA v1.0</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"font-size: small;\"><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\">Call-specific instructions</span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-financial-support-to-third-parties_he_en.docx\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Information on financial support to third parties (HE)</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/temp-form/af/information-on-clinical-studies_he_en.docx\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Information on clinical studies (HE)</span></span></a></span></p>\n<h2><span style=\"color: rgb(0, 0, 0);\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><b><span lang=\"EN-US\">Additional documents:</span></b></span></span></span></h2>\r\n<h2><b><span lang=\"EN-US\"><o:p></o:p></span></b></h2>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://globalhealth-edctp3.eu/sites/default/files/2023-12/WP%202024%20Main.pdf\" target=\"_blank\">GH EDCTP3 - WP 2024</a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://globalhealth-edctp3.eu/sites/default/files/2023-12/WP%202024%20Annex1A%20Call%20for%20proposals.pdf\" target=\"_blank\">GH EDCTP3 - WP 2024 Annex1A - Calls for Proposals</a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://globalhealth-edctp3.eu/sites/default/files/2023-12/WP%202024%20Annex1B%20IKAA.pdf\" target=\"_blank\">GH EDCTP3 - WP 2024 Annex1B - IKAA</a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-1-general-introduction_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 1. General Introduction</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-4-health_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 4. Health</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/wp-call/2023-2024/wp-13-general-annexes_horizon-2023-2024_en.pdf\" target=\"_blank\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Main Work Programme 2023&ndash;2024 &ndash; 13. General Annexes</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">HE Programme Guide</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021R0695\" target=\"_blank\" style=\"font-family: Arial;\"><span style=\"font-size: small;\">HE Framework Programme and Rules for Participation Regulation 2021/695</span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\" style=\"color: rgb(64, 64, 64);\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32021D0764\" target=\"_blank\"><span style=\"font-size: small;\">HE Specific Programme Decision 2021/764</span></a></span></span></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://eur-lex.europa.eu/legal-content/EN/ALL/?uri=CELEX:32018R1046&amp;qid=1535046024012\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">EU Financial Regulation</span></span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/rules-lev-lear-fca_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Rules for Legal Entity Validation, LEAR Appointment and Financial Capacity Assessment</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/aga_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">EU Grants AGA </span>&mdash; Annotated Model Grant Agreement</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\"><span lang=\"EN-US\">Funding &amp; Tenders Portal Online Manual</span></span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/tc_en.pdf\"><span style=\"font-size: small;\"><span style=\"font-family: Arial;\">Funding &amp; Tenders Portal Terms and Conditions</span></span></a></p>\r\n<p class=\"MsoNormal\" style=\"margin-bottom:0cm;margin-bottom:.0001pt\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/ftp/privacy-statement_en.pdf\" style=\"font-size: 11pt; font-family: Arial;\"><span style=\"font-size: small;\">Funding &amp; Tenders Portal Privacy Statement</span></a></p>", "supportInfo": "<p><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;&#10;font-weight:normal;mso-bidi-font-weight:bold\"><b><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/common/guidance/om_en.pdf\" target=\"_blank\">Online Manual</a>&nbsp;</b></span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">is your guide on the procedures from proposal submission to managing your grant.<o:p></o:p></span></p>\r\n<p><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/programme-guide_horizon_en.pdf\" target=\"_blank\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\">Horizon Europe Programme Guide</span></b></a><strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;</span></strong><strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif; font-weight: normal;\">contains the detailed guidance to the structure, budget and political priorities of Horizon Europe.</span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/faq;type=undefined;categories=;programme=H2020;actions=;keyword=\" target=\"_blank\">Funding &amp; Tenders Portal FAQ</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;&ndash; find the answers to most frequently asked questions on submission of proposals, evaluation and grant management.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/research-and-innovation/contact/research-enquiry-service_en\" target=\"_blank\">Research Enquiry Service</a></span>&nbsp;</b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; ask questions about any aspect of European research in general and the EU Research Framework Programmes in particular.</span></p>\r\n<p><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></p>\r\n<p><b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/ncp\" target=\"_blank\">National Contact Points (NCPs)</a>&nbsp;</span></b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; get guidance, practical information and assistance on participation in Horizon Europe. There are also NCPs in many non-EU and non-associated countries (&lsquo;third-countries&rsquo;).<b><o:p></o:p></b></span></p>\r\n<p><a href=\"https://een.ec.europa.eu/\" target=\"_blank\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\">Enterprise Europe Network</span></b></a><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;&#10;color:#003366\">&nbsp;</span></strong><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash; contact your EEN national contact for advice to businesses with special focus on SMEs. The support includes guidance on the EU research funding.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks/contact-form\" target=\"_blank\">IT Helpdesk</a></span></b>&nbsp;</span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&ndash;&nbsp;contact the Funding &amp; Tenders Portal IT helpdesk for questions such as forgotten passwords, access rights and roles, technical aspects of submission of proposals, etc.<o:p></o:p></span></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://www.iprhelpdesk.eu/\" target=\"_blank\">European IPR Helpdesk</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;assists you on intellectual property issues.<br />\r\n<br />\r\n</span><b><a href=\"mailto:research@cencenelec.eu\" target=\"_blank\">CEN-CENELEC Research Helpdesk</a> and <a href=\"https://www.etsi.org/research/helpdesk\" target=\"_blank\">ETSI Research Helpdesk</a></b>&nbsp;<span style=\"font-family: Arial, sans-serif;\">&ndash;&nbsp;</span>the European Standards Organisations&nbsp;advise you how to tackle standardisation in your project proposal.&nbsp;&nbsp;</p>\r\n<p class=\"MsoNormal\" style=\"margin-left:36.0pt\"><o:p></o:p></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://euraxess.ec.europa.eu/sites/default/files/am509774cee_en_e4.pdf\" target=\"_blank\">The European Charter for Researchers and the Code of Conduct for their recruitment</a></span></b></span><span style=\"font-size:&#10;9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#003366\"> </span><strong><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif;color:#003366;font-weight:&#10;normal;mso-bidi-font-weight:bold\">&ndash; consult the general principles and requirements specifying the roles, responsibilities and entitlements of researchers, employers and funders of researchers.</span></strong><b><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\"><o:p></o:p></span></b></p>\r\n<p><span class=\"MsoHyperlink\"><b><span style=\"font-size:9.0pt;font-family:&quot;Arial&quot;,sans-serif\"><a href=\"https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/how-to-participate/partner-search\" target=\"_blank\">Partner Search Services</a></span></b></span><span style=\"font-size: 9pt; font-family: Arial, sans-serif;\">&nbsp;help you find a partner organisation for your proposal.<o:p></o:p></span></p>\r\n<p>&nbsp;</p>", "sepTemplate": "<p>To access the Electronic Submission Service, please click on the submission-button next to the <strong>type of action</strong> and the <strong>type of model grant agreement</strong> that corresponds to your proposal. You will then be asked to confirm your choice, as it cannot be changed in the submission system. Upon confirmation, you will be linked to the correct entry point.</p>\r\n<p>To access existing draft proposals for this topic, please login to the Funding &amp; Tenders Portal and select the My Proposals page of the My Area section.</p>", "links": [], "additionalDossiers": [], "infoPackDossiers": [], "callDetailsJSONItem": {"additionalInfo": "<p>&nbsp;<strong style=\"color: rgb(51, 51, 51); font-family: &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; font-size: 13.718px;\"><u>Expected Impacts</u></strong></p>\r\n<p style=\"color: rgb(51, 51, 51); font-family: &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; font-size: 13.718px;\">Activities funded under the 2024 work programme of the Global Health EDCTP3 JU calls for proposals should contribute to:</p>\r\n<ul level=\"0\" style=\"color: rgb(51, 51, 51); font-family: &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; font-size: 13.718px;\">\r\n    <li>Achieve SDG3 &lsquo;Ensure healthy lives and promote well-being for all at all ages&rsquo; in sub-Saharan African (SSA) countries;</li>\r\n    <li>Enable the implementation of the short- and medium-term actions foreseen by the AU EU Innovation Agenda (adopted in July 2023) in the area of public health and the EU Global Health Strategy (November 2022);</li>\r\n    <li>Improve equitable access to a full range of essential health services from health promotion to disease prevention and affordable quality treatment, rehabilitation and palliative care to fight communicable diseases;</li>\r\n    <li>Expand partnerships based on equal footing, co-ownership, mutual interest and strategic priorities;</li>\r\n    <li>Enhance sustainable global scientific collaboration in health research and international cooperation across sub-Saharan Africa.</li>\r\n    <li>Improve opportunities for training of researchers and healthcare professionals in sub-Saharan Africa.</li>\r\n</ul>", "latestInfos": [{"approvalDate": "Jul 26, 2024 4:42:13 PM", "lastChangeDate": "Jul 26, 2024 4:42:13 PM", "content": "<p><span style=\"color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 16px;\">The 2</span><span style=\"box-sizing: inherit; line-height: 0; position: relative; vertical-align: initial; top: -0.5em; color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif;\">nd</span><span style=\"color: rgb(64, 64, 64); font-family: Arial, &quot;Helvetica Neue&quot;, Helvetica, sans-serif; font-size: 16px;\">&nbsp;stage deadline has been postponed to 01/10/2024</span></p>"}, {"approvalDate": "Jul 23, 2024 10:23:15 PM", "lastChangeDate": "Jul 23, 2024 10:23:15 PM", "content": "<p>EVALUATION RESULTS (STAGE 1)</p>\r\n<p>Published: 17/01/24</p>\r\n<p>Deadline: 04/04/24</p>\r\n<p>Available budget: EUR 3 500 000&nbsp;</p>\r\n<p>In accordance with the call conditions, the evaluation of the first-stage proposals was made looking only at the criteria 'Excellence' and 'Impact'. The threshold for both criteria was 4. The overall threshold (applying to the sum of the two individual scores) was set for each topic/type of action with separate call-budget-split at a level that allowed the total requested budget of proposals admitted to stage 2 be as close as possible to 3 times the available budget (and not below 2.5 times the budget):</p>\r\n<ul>\r\n    <li>HORIZON-JU-GH-EDCTP3-2024-02-01-two-stage: 8 points</li>\r\n</ul>\r\n<div><span style=\"font-family: Arial, sans-serif; font-size: 13.3333px;\">The results of the evaluation for each topic are as follows:</span></div>\r\n<div>\r\n<table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"234\" style=\"border-collapse:&#10; collapse;width:176pt\">\r\n    <colgroup><col width=\"143\" style=\"mso-width-source:userset;mso-width-alt:5003;width:108pt\" />  <col width=\"91\" style=\"mso-width-source:userset;mso-width-alt:3165;width:68pt\" />  </colgroup>\r\n    <tbody>\r\n        <tr height=\"67\" style=\"height:50.0pt\">\r\n            <td height=\"67\" class=\"xl66\" width=\"143\" style=\"height:50.0pt;width:108pt\">&nbsp;</td>\r\n            <td class=\"xl67\" width=\"91\" style=\"border-left:none;width:68pt\">HORIZON-JU-GH-EDCTP3-2024-02-01-two-stage</td>\r\n        </tr>\r\n        <tr height=\"67\" style=\"height:50.0pt\">\r\n            <td height=\"67\" class=\"xl68\" width=\"143\" style=\"height:50.0pt;border-top:none;&#10;  width:108pt\">Number of proposals submitted (including proposals transferred   from or to other calls)</td>\r\n            <td class=\"xl69\" width=\"91\" style=\"border-top: none; border-left: none; width: 68pt; text-align: center;\">10</td>\r\n        </tr>\r\n        <tr height=\"33\" style=\"height:25.0pt\">\r\n            <td height=\"33\" class=\"xl68\" width=\"143\" style=\"height:25.0pt;border-top:none;&#10;  width:108pt\">Number of inadmissible proposals</td>\r\n            <td class=\"xl69\" width=\"91\" style=\"border-top: none; border-left: none; width: 68pt; text-align: center;\">0</td>\r\n        </tr>\r\n        <tr height=\"33\" style=\"height:25.0pt\">\r\n            <td height=\"33\" class=\"xl68\" width=\"143\" style=\"height:25.0pt;border-top:none;&#10;  width:108pt\">Number of ineligible proposals</td>\r\n            <td class=\"xl69\" width=\"91\" style=\"border-top: none; border-left: none; width: 68pt; text-align: center;\">5</td>\r\n        </tr>\r\n        <tr height=\"33\" style=\"height:25.0pt\">\r\n            <td height=\"33\" class=\"xl68\" width=\"143\" style=\"height:25.0pt;border-top:none;&#10;  width:108pt\">Number of above-threshold proposals</td>\r\n            <td class=\"xl69\" width=\"91\" style=\"border-top: none; border-left: none; width: 68pt; text-align: center;\">4</td>\r\n        </tr>\r\n        <tr height=\"50\" style=\"height:37.5pt\">\r\n            <td height=\"50\" class=\"xl68\" width=\"143\" style=\"height:37.5pt;border-top:none;&#10;  width:108pt\">Total budget requested for above-threshold proposals</td>\r\n            <td class=\"xl70\" width=\"91\" style=\"border-top: none; border-left: none; width: 68pt; text-align: center;\">13.993.328</td>\r\n        </tr>\r\n    </tbody>\r\n</table>\r\n</div>\r\n<div>&nbsp;</div>\r\n<div>Summary of observer report:</div>\r\n<div><em>A single Independent Observer (IO) reviewed the evaluation of this call. This enabled the IO to follow the entire process, to identify strengths and areas for possible improvements specific to the first stage evaluation, and to compare procedures and practices of a fully online evaluation with online consensus meetings and online discussions and suggest recommendations for the second stage. </em></div>\r\n<div><em>Global Health EDCTP3 staff ensured that for all the proposals associated to this call, all actors involved were fully informed about the background guidance and legal documents, procedures and standards of quality. The organization and management went smoothly. </em></div>\r\n<div><em>The overall evaluation process was executed in full compliance with the procedures, code of conduct, and guiding principles of fairness, transparency and equal treatment of proposals. The rules and guiding principles for the procedures concerning each evaluation step were known in advance to the applicants, the evaluators and all the persons involved in the evaluations. </em></div>\r\n<div><em>The briefing materials made available to the external experts were of the highest quality as they provided all the relevant information in a clear and comprehensive way. Experts were asked to declare any potential conflict of interest and to ensure confidentiality of all information. </em></div>\r\n<div><em>The evaluation process was robust. No preferential treatment of any proposal was observed by the observer or reported by any expert. The discussions were fair and consistent with open and detailed online deliberations covering all the criteria and sub criteria to ensure clarity of issues arising and providing impartial feedback to applicants. </em></div>\r\n<div>&nbsp;</div>\r\n<div>\r\n<p class=\"MsoNormal\"><span lang=\"EN-GB\">We recently informed the applicants about the evaluation results for their proposals.&nbsp;</span></p>\r\n<p class=\"MsoNormal\"><span lang=\"EN-GB\" style=\"font-size: 10pt; font-family: Arial, sans-serif;\">For questions, p</span><span lang=\"EN-GB\" style=\"font-size: 10pt; font-family: Arial, sans-serif;\">lease contact&nbsp;EC-GLOBAL-HEALTH-EDCTP3@ec.europa.eu</span></p>\r\n</div>\r\n<p>&nbsp;</p>"}, {"approvalDate": "Apr 10, 2024 10:04:06 PM", "lastChangeDate": "Apr 10, 2024 10:04:06 PM", "content": "<p>Call HORIZON-JU-GH-EDCTP3-2024-02-two-stage closed on April 4th, 2024.</p>\r\n<p>10 proposals have been submitted.</p>\r\n<p>Evaluation results are expected to be communicated in July 2024.</p>\r\n<div>&nbsp;</div>"}, {"approvalDate": "Jan 18, 2024 12:00:06 AM", "lastChangeDate": "Jan 18, 2024 12:00:06 AM", "content": "The submission session is now available for: HORIZON-JU-GH-EDCTP3-2024-02-01-two-stage(HORIZON-JU-CSA)"}], "hasForthcomingTopics": false, "hasOpenTopics": false, "allClosedTopics": true}}}